Pin1 Acts As a Modulator of Cell Proliferation Through Alteration in NF-κB but Not β-catenin/TCF4 Signalling in a Subset of Endometrial Carcinoma Cells
Affiliations
Prolyl isomerase Pin1 is frequently up-regulated in a variety of human malignancies, modulating signalling in several oncogenic pathways, including those involving NF-κB and β-catenin. Our previous study provided evidence that alterations in these signal pathways are essential events during trans-differentiation of endometrial carcinoma (Em Ca) cells. Here we focused on the functional roles of Pin1. In normal endometrium, Pin1 expression showed a stepwise decrease from proliferative to secretory phases during the menstrual cycle, correlating positively with cell proliferation and expression of several cell cycle-related molecules including E2F1 and pRb. Transfection of E2F1 caused transactivation of Pin1, indicating control by E2F1/Rb pathways. In Em Cas with morules, Pin1 expression was found to be significantly increased in glandular but not in morular components, correlating inversely with nuclear accumulation of β-catenin. Overexpression also caused an increase in the stability of nuclear p65, leading to enhancement of NF-κB-mediated transactivation of the cyclin D1 gene, in contrast to minimal inhibition of β-catenin/TCF4 transcription activity. These findings indicate that Pin1 may play an important role in preserving cell proliferative activity in glandular carcinoma components through enhancement of NF-κB signalling, but its down-regulation may be a key signal for induction of trans-differentiation of Em Ca cells, contributing to a shift from NF-κB to β-catenin/TCF signalling pathways.
Wang Y, Zhu W, Ma R, Tian Y, Chen X, Gao P J Cell Mol Med. 2023; 28(1):e18022.
PMID: 37929660 PMC: 10805483. DOI: 10.1111/jcmm.18022.
Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy.
Chuang H, Zhen Y, Tsai Y, Chuang C, Huang M, Hsiao M Biomedicines. 2021; 9(4).
PMID: 33807199 PMC: 8065645. DOI: 10.3390/biomedicines9040359.
Kim Y, Ji Y, Kim N, Van Tu N, Rho J, Jeong E Mar Drugs. 2021; 19(2).
PMID: 33557170 PMC: 7913985. DOI: 10.3390/md19020090.
Sun Q, Fan G, Zhuo Q, Dai W, Ye Z, Ji S Cell Prolif. 2020; 53(5):e12816.
PMID: 32347623 PMC: 7260075. DOI: 10.1111/cpr.12816.
Prolyl Isomerase Pin1 in Human Cancer: Function, Mechanism, and Significance.
Pu W, Zheng Y, Peng Y Front Cell Dev Biol. 2020; 8:168.
PMID: 32296699 PMC: 7136398. DOI: 10.3389/fcell.2020.00168.